Characterization of telaprevir treatment outcomes and resistance in patients with prior treatment failure: Results from the REALIZE trial-Reference-Cited by-同舟云学术

Characterization of telaprevir treatment outcomes and resistance in patients with prior treatment failure: Results from the REALIZE trial

Published:2012-12 Issue:6 Volume:56 Page:2106-2115
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

De Meyer Sandra,Dierynck Inge,Ghys Anne,Beumont Maria,Daems Bjorn,Van Baelen Ben,Sullivan James C.,Bartels Douglas J.,Kieffer Tara L.,Zeuzem Stefan,Picchio Gaston

Publisher

Wiley

Subject

Hepatology

Reference29 articles.

1. VX-950, a novel hepatitis C virus (HCV) NS3-4A protease inhibitor, exhibits potent antiviral activities in HCV replicon cells;Lin;Antimicrob Agents Chemother,2006

2. Response-guided telaprevir combination treatment for hepatitis C virus infection;Sherman;N Engl J Med,2011

3. Telaprevir for previously untreated chronic hepatitis C virus infection;Jacobson;N Engl J Med,2011

4. Telaprevir for retreatment of HCV infection;Zeuzem;N Engl J Med,2011

5. European Medicines Agency ® 2011 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002313/WC500115529.pdf

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Era of direct acting anti-viral agents for the treatment of hepatitis C;World Journal of Hepatology;2018-10-27

2. Modelling how responsiveness to interferon improves interferon-free treatment of hepatitis C virus infection;PLOS Computational Biology;2018-07-12

3. Direct-acting antivirals for chronic hepatitis C;Cochrane Database of Systematic Reviews;2017-09-18

4. Fibrosing Cholestatic Hepatitis C After Liver Transplantation: Therapeutic Options Before and After Introduction of Direct-Acting Antivirals: Our Experience and Literature Review;Transplantation Proceedings;2017-07

5. Direct-acting antivirals for chronic hepatitis C;Cochrane Database of Systematic Reviews;2017-06-06